ALS Untangled does not endorse Acuscope for slowing ALS progression
Original source
Acuscope (opens in a new tab)ALS Untangled reviewed Acuscope, a treatment device, and found no clear evidence that it slows, stops or reverses amyotrophic lateral sclerosis (ALS). The review described one person with primary lateral sclerosis and one person with ALS whose progression measurements changed slightly during treatment, but said these changes could reflect natural variation rather than Acuscope.
Why this matters
People with ALS or primary lateral sclerosis should not consider these observations proof that Acuscope changes disease progression. ALS Untangled said the device appears reasonably safe, but its usefulness and mechanism remain unclear, so the review does not endorse it for slowing, stopping or reversing ALS.
Limitations and context
This is an independent expert review, not a controlled clinical trial. It discusses observations from only two people, and the review says natural disease variation makes the treatment effect unclear.